Random header image... Refresh for more!

J&J – Conor CoStar(r) Clinical Trial Stent Stopped

by admin

Conor Medsystems, LLC has concluded that the COSTAR II (CObalt Chromium STent with Antiproliferative for Restenosis) trial, the pivotal study for the CoStar® cobalt chromium paclitaxel-eluting coronary stent, failed to meet its primary endpoint.

Bookmark and Share

Related posts:

  1. Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System
  2. NEJM — Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction
  3. Clinical and Angiographic Outcomes After Placement of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions
  4. FDA Statement on Coronary Drug-Eluting Stents
  5. J&J Cypher Stent Sort Out III Study VS Medtronic Endeavor Stent

0 comments

There are no comments yet...

Kick things off by filling out the form below.

Leave a Comment